Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study
Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia
top of page
bottom of page
Darren Wogman MSc
123-456-7890
Clinical Trial Dataset Analysis - A phase 2a efficacy, safety and tolerability study on treating patients with schizophrenia